Hepatotoxicity from oral anabolic steroids results from the 17-alpha alkylation (17-AA) modification that allows these compounds to survive first-pass hepatic metabolism. This modification impairs normal hepatocyte function, blocks bile secretion (cholestasis), and in severe or prolonged cases can cause peliosis hepatis (blood-filled cysts), hepatic adenomas, or hepatocellular carcinoma.
GearCheck connects glossary concepts to your actual bloodwork — showing exactly where your values sit and what they mean in the context of your protocol.
Analyze My Bloodwork →GearCheck provides blood marker analysis and harm reduction education. Information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional.